Table 1 Anthropometric measures and adipose tissue weight of obese rats treated with zinc oxide nanoparticles.

From: Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload

Parameter

Treatment

Control

Obese

O + ZnONPs 5 mg/kg

O + ZnONPs 10 mg/kg

Body weight (g)

Starting

242.00 ± 7.33

341.80 ± 8.65*

320.66 ± 11.34*

331.90 ± 12.69*

Final

300.78 ± 5.43

489.43 ± 13.15*@

428.36 ± 12. 00 *@

395.74 ± 13.00*@#

% of change

24.30%

43.19%

33.59%

19.28%

BMI (g/cm2)

Starting

0.55 ± 0.011

0.76 ± 0.020*

0.72 ± 0.028*

0.74 ± 0.032*

Final

0.59 ± 0.010

0.95 ± 0.018*

0.85 ± 0.013*@

0.78 ± 0.012*@#

% of change

7.27%

25.00%

18.00%

5.41%

Abdominal circumference(cm)

Starting

13.53 ± 0.30

18.63 ± 0.18*

17.63 ± 0.38*

17.81 ± 0.32*

Final

15.63 ± 0.42

23.13 ± 0.23*

18.63 ± 0.26*@

19.00 ± 0.38*@

% of change

15.52%

24.15%

5.67%

6.68%

Adipose tissue weight (g)

Epididymal

2.34 ± .0.28

6.40 ± 0.56*

4.35 ± 0.31*@

4.67 ± 0.19*@

Visceral

2.81 ± 0.26

16.01 ± 0.86*

10.17 ± 0.28*@

8.10 ± 0.29*@#

Food intake (g/day)

13.55 ± 1.00

19.43 ± 0.78*

16.32 ± 0.57*@

15.47 ± 1.00 *@

  1. Each value represents the mean of 8 animals ± SE. Statistical analysis was performed using one-way ANOVA followed by Tukey–Kramer multiple comparisons test (* vs control group, @vs obese group and #vs ZnONPs 5 mg/kg) at p < 0.05. O: Obese.
Back to article page